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ABSTRAK 
HARTAWAN, R., K. ROBINSON, T. MAHONY dan J. MEERS. 2011. Ekspresi gen H5 dan N1 dari virus avian influenza secara in vitro 
menggunakan Green Fluorescent Protein sebagai reporter. JITV 16(3): 234-241. 
Hemaglutinin dan neuraminidase merupakan protein yang bersifat immunogenik dari virus avian influenza yang banyak 
digunakan dalam penelitian rekombinan. Namun, kedua gen tersebut bermutasi dengan cepat sehingga terbentuk variasi genotipe 
yang sangat beragam. Hal ini sangat mempengaruhi tingkat ekspresi dalam sistem rekombinan. Tujuan penelitian ini adalah 
untuk mengetahui tingkat ekspresi gen H5 dan N1 yang diisolasi dari isolat lapang virus avian influenza dengan cara 
mengkloning kedua gen tersebut pada vektor ekspresi pEGFP-C1. Dua klon pEGFP-C1 yang mengandung gen H5 maupun N1 
ditransfeksikan pada sel chicken embryo fibroblasts (CEF), rabbit kidney (RK13) dan African green monkey kidney (VERO) 
menggunakan reagen Lipofectamine ‘Plus’. Hasil penelitian menunjukkan tingkat ekspresi gen pada sel VERO lebih tinggi 
dibandingkan dengan sel RK13 maupun CEF. Pengamatan dengan mikroskop fluorescent dan Western blotting menunjukkan 
bahwa gen N1 diekspresikan lebih baik di semua sel dibandingkan dengan gen H5. 
Kata Kunci: H5N1 Virus, Hemagglutinin, Neuraminidase, Ekspresi Gen, Green Fluorescent Protein 
ABSTRACT 
HARTAWAN, R., K. ROBINSON, T. MAHONY and J. MEERS. 2011. In vitro expression of native H5 and N1 genes of avian influenza 
virus by using Green Fluorescent Protein as reporter. JITV 16(3): 234-241. 
The hemagglutinin and neuraminidase are important immunogen of avian influenza virus that are suitable for recombinant 
experimentation. However, both genes have been experienced rapid mutation resulting in diverse variety of genotypes. Hence, 
gene expression in recombinant systems will be difficult to predict. The objective of the study was to examine expression level 
of H5 and N1 genes from a field isolate by cloning the genes into expression vector pEGFP-C1. Two clones respresenting full-
length of H5 and N1 gene in plasmid pEGFP-C1 were transfected into chicken embryo fibroblasts (CEF), rabbit kidney (RK13) 
and African green monkey kidney (VERO) cells using Lipofectamine ‘Plus’ reagent. The experiment showed level of gene 
expression in the VERO cell was higher than in the RK13 and CEF cells. Observations using fluorescent microscopy and 
Western blotting revealed that the N1 gene was expressed better in all cells compared to the H5 gene. 
Key Words: H5N1 Virus, Hemagglutinin, Neuraminidase, Gene Expression, Green Fluorescent Protein 
INTRODUCTION 
The genetic features of HPAI virus strain H5N1 
have been extensively investigated in an endeavor to 
gain better understanding of virus nature in order to 
develop appropriate approaches against the disease. In 
area of bird vaccination, a recombinant system may 
provide a suitable alternative since inactivated vaccine 
appears to be ineffective for preventing outbreak 
recurrence within vaccinated flocks (CHEN et al., 2008; 
LIPATOV et al., 2004). Therefore, numerous 
recombinant investigations have been performed in 
attempt to improve vaccine performance (CRAWFORD et 
al., 1999; PAVLOVA et al., 2009; TORO et al., 2008; 
VEITS et al., 2006; YANG et al., 2007). Since virus 
possesses several determinants that are capable of 
inducing immune responses (PERDUE, 2008), many 
possibilities for recombinant study are available. 
Nevertheless, hemagglutinin and neuraminidase are the 
most suitable antigen for recombinant experimentation 
because both are surface exposed glycoprotein and 
strongly immunogenic. 
The hemagglutinin and neuraminidase are exterior 
glycoproteins that play important roles in the replication 
of avian influeza virus (AIV) (COLMAN, 1998; 
STEINHAUER and WHARTON, 1998). Whereas 
hemagglutinin is a trimer protein involving in cellular 
attachment in initial stage (STEINHAUER and WHARTON, 
1998; WEIS et al., 1988), neuraminidase is a tetramer 
protein contributing to release virus in final stage of the 
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replication (COLMAN, 1998; COLMAN et al., 1983). The 
hemagglutinin and neuraminidase are encoded by genes 
located on different segment, which are segment 4 and 
6 respectively (HAY, 1998). These genes undergo rapid 
mutation resulting in massive genetic variance 
(DUVVURI et al., 2009). As a consequence, expression 
of these genes can be difficult due to predicted 
differences in codon usage pattern between the genes 
and genetic system of the target cell (GREENE, 2004). 
The aim of the study was to investigate in vitro 
expression level of the H5 and N1 genes from an 
Indonesian AIV isolate A/duck/Tangerang/Bbalitvet-
ACIAR-TE11/2007. The gene expression was prefered 
in euracaryotic cells to in procaryotic cells because the 
outcome of the study was addressed for recombinant 
purpose with avian herpesvirus vector that is also 
primarily undertaken in the eucaryotic model. The 
expression study was undertaken by inserting the native 
genes into an expression vector pEGFP-C1 that is 
straightforward to examine gene expression in 
eucaryotic cells. Therefore, the gene fusion product was 
utilised to determine the expression level of the H5 and 
N1 genes from the isolate in order to assess the 
possibility of utilizing these native genes in a 
recombinant study. 
MATERIALS AND METHODS 
Site and time of study 
The expression study of the H5 and N1 genes of the 
field isolate was mainly undertaken in DPIF-QLD 
Laboratorium (Brisbane, Australia) from August 2009 
to February 2010. However, the preliminary studies 
such as virus isolation, isolation and cloning of genes 
were carried out in Virology Laboratorium, IRCVS 
(Bogor, Indonesia). Molecular characterisation of the 
genes was accomplished in Australia (HARTAWAN et 
al., 2010). 
Source of Hemagglutinin and Neuraminidase gene 
The native genes (H5 and N1) that were isolated 
from the field isolate using an RT-PCR protocol were 
subsequently cloned into pGEM®-T Easy vector system 
(Promega Corporation) as previously described 
(HARTAWAN et al., 2010). The clones derived from the 
study were utilised in the analysis of gene expression as 
in vitro study. 
The full-length of H5 gene (1,707 bp) was 
assembled from existing overlapped clones {H5.1 (817 
bp) & H5.2 (949 bp)} (HARTAWAN et al., 2010). 
Furthermore, these fragments were joined using a PCR 
protocol and subsequently were cloned into pGEM®-T 
Easy vector system (Promega Corporation). This 
technique successfully generated new clones carrying 
full-length H5 gene. The one clone of pGEM-TE/H5 
(#26) was selected for the expression trial since it 
retains identical sequence to its origin. Meanwhile, the 
expression of N1 gene was performed from clone 
pGEM-TE/N1#15 containing full-length of the N1 
gene. 
Construction of Expression Plasmids pEGFP-C1 
containing H5 or N1 Gene 
Expression Plasmid pEGFP-C1 
The commercial expression plasmid pEGFP-C1 
(Clontech) were utilised to express the native H5 and 
N1 genes of the Indonesian isolate. This vector has been 
already utilised in gene expression study as in cell 
culture model (XU et al., 2006). 
Introduction of a Restriction Site into H5 and N1 
Genes 
Primer sequences for cloning the H5 and N1 genes 
are presented in Table 1. The forward primers were 
added with a XhoI restriction site and optimized with 
Kozak’s analysis sequence (KOZAK, 1987; 1990). 
Meanwhile, the reverse primers encoded for a six 
histidine peptide tag and stop codon followed by an 
ApaI site at the end of sequence. 
The PCR protocol was carried out in a 20 μl mixture 
containing 2 μl of 10X PCR buffer, 0.75 μl of 10 mM 
dNTP’s, 0.5 μl of 50 mM MgCl2, 0.5 μl of each 
respective forward and reverse primer (20 µM), 14.25 
μl of RNase free water, 0.5 μl of Platinum® Taq DNA 
Polymerase (INVITROGEN™) enzyme mix, and 1 μl 
of respective gene in the plasmid as template. 
The PCR conditions were designed in two 
continuous steps with similar conditions for both genes. 
Step I was 94°C for 2 min (initial DNA denaturation), 
10 cycles of 94°C for 15 s (denaturation), 55°C for 30 s 
(annealing), and 72°C for 1.5 min (extension) with final 
extension at 72°C for 3 min. The process was directly 
continued by Step II, which was 25 cycles of 94°C for 
15 s (denaturation), and 72°C for 1.5 min (annealing 
and extension) with final extension at 72°C for 3 min, 
and hold temperature at 4°C. The DNA products were 
visualized by electrophoresis in 1% agarose gel. The 
amplified DNA fragments of H5 and N1 gene were 
purified by using a QIAquick PCR purification kit 
(QIAGEN®) and quantified using NanoDrop 1000 
spectrophotometer (Thermo Fisher Scientific Inc.). 
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Table 1. Oligonucleotide primers to introduce XhoI and ApaI restriction sites into the sequence termini of the H5 and N1 genes 
Gene Primer Primer sequence (5’-3’) 
Hemagglutinin H5f-XhoI GGGACTCGAGCCATGGAGAAAATAGTGCTTCTTCTTGC 
H5r-6His-ApaI TCAGGGGCCCTTAatgatgatgatgatgatgAATGCAAATTCTGCATTG
TAACGATCC 
Neuraminidase N1f-XhoI GGGACTCGAGCCATGAATCCAAATCAGAAGATAATAACC 
N1r-6His-ApaI GCAGGGGCCCTTAatgatgatgatgatgatgCTTGTCAATGGTGAATG
GCAACTC 
Restriction enzyme sites are shown in bold letter. The consensus Kozak’s sequence in the forward primers is underlined. The six-histidine 
peptide tag added to the reverse primers is shown in lowercase text 
 
Cloning of H5 and N1 genes into plasmid pEGFP-C1 
Preparation of gene insertion into plasmid pEGFP-
C1 was performed by sequential digestion of all genetic 
material using ApaI and XhoI restriction enzymes 
(NEW ENGLAND Biolabs®Inc.), including plasmid 
pEGFP-C1 and purified PCR product of the H5 and N1 
genes. Briefly, 5 µg respective DNA and 2U of ApaI 
were incubated at 25oC (room temperature) for 1.5 h 
with supplementation 5 μl of 1x NEB Buffer 3 and 100 
µg/ml BSA. Subsequently, 2U of XhoI was added into 
mixture and digestion was continued by incubation at 
37oC for 1.5 h. The digestion was visualized by 
electrophoresis in 1% Agarose gel. The fragments of 
plasmid and genes were purified from agarose gel using 
QIAQuick gel extraction kit (QIAGEN®) as per 
manufacturer’s instruction and quantified using 
NanoDrop 1000 spectrophotometer (Thermo Fisher 
Scientific Inc.). 
The cloning of digested H5 or N1 gene into plasmid 
pEGFP-C1 (Clontech) was performed using the T4 
DNA ligation and buffer solution of pGEM®-T Easy 
vector system (Promega Corporation) as per 
manufacturer’s instruction. Subsequently, the plasmids 
with gene insertion were transformed into 
electrocompetent Escherichia coli strain DH10B 
(INVITROGEN™) by electroporation (1.8 KV, 4.10 
mS). The transformed cells were inoculated on LB agar 
plate in presence of 30 µg/ml Kanamycin. Screening 
test by PCR was performed on colonies in order to 
ensure correct insertion (HARTAWAN et al., 2010). 
Several positive clones were propagated in 10 ml of LB 
broth with addition of 100 µg/ml Kanamycin at 37oC 
for overnight with gentle agitation. Half of the culture 
was stored as a glycerol stock, while the recombinant 
plasmid was purified from the remaining culture using 
the QIAGEN® Plasmid Mini Kit (QIAGEN®) as per 
manufacturer’s instruction. Subsequently, the purified 
plasmids were quantified using NanoDrop 1000 
spectrophotometer (Thermo Fisher Scientific Inc.). 
Subsequently, the plasmids with gene inserts were 
delivered to AGRF Brisbane for sequencing in order to 
select suitable clones for the expression trial. Several 
primers were utilised in sequencing, included H5 and 
N1 internal primers (HARTAWAN et al., 2010) as well as 
the green fluorescence protein primer (gfp seg C 
primer: 5’ – CATGGTCCTGCTGGAGTTCGTG – 3’).  
Transfection of recombinant expression plasmids 
into cell cultures 
Three different eukaryotic cell cultures were 
utilised, including CEF, RK13, and VERO. Whereas 
CEF cell was cultured in Media 199 (INVITROGEN™) 
with 10% fetal calf serum, RK13 and VERO were 
cultured in MEM (INVITROGEN™) with of 10% fetal 
calf serum. All cultures were incubated at 37oC in a 
humidified atmosphere with 5% CO2. 
The recombinant expression plasmids were 
transfected into cells using the Lipofectamine enhanced 
with ‘Plus’ reagent (INVITROGEN™). Since presence 
of serum can inhibit the transfection process, OptiMEM 
media (INVITROGEN™) was utilised for transfection. 
Briefly, the cells was seeded in 6 well/plate flask 
(NUNC) with concentration of 5x105 cells/ml and 
subsequently incubated for 18-24 h to achieve about 
90% confluence.  Each of the respective recombinant 
plasmid (1 μg) was diluted with OptiMEM into a final 
volume of 100 μl following the addition 16 μl of 
‘PLUS’ reagent. The mixtures were incubated at room 
temperature for 15 min. At the same time, 8 μl of 
Lipofectamine transfection reagent was diluted with 
OptiMEM into volume of 100 μl. Subsequently, the 
diluted Lipofectamine was added into the mixture of 
DNA and ‘PLUS’ reagent, followed by 45 min 
incubation at room temperature.  
Meanwhile, the cultures were washed twice with 1 x 
RT-PBS and once with RT-OptiMEM. Approximately 
800 μl of OptiMEM was added into each transfection 
well. Then, ~200 μl of DNA/Lipofectamine Plus 
reagent mixtures were gently added to the respective 
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washed culture. All cultures were then incubated at 
37oC, in a humidified atmosphere, and 5% CO2. After 
20 h, culture integrity was checked by microscopy. If 
the cells appeared disrupted, the OptiMEM was 
replaced with a new culture media (Media 199 for CEF 
and MEM for VERO & RK13).  
The results of the transfection were observed for 72 
h with daily observation. Every 24 h, sample cell 
culture for each plasmid was collected for analysis. For 
collection, the culture was washed with once with 
1XRT-PBS and the monolayer was scraped. The cell 
suspension in microfuge was pelleted by centrifugation 
in maximum speed at 4oC. After PBS was removed, the 
pellet was stored at -20oC. 
Detection of gene expression in cell cultures 
The level of protein expression of the respective 
recombinant clone of the pEGFP-C1 vector was 
analyzed using fluorescent microscope and Western 
blotting. The level of the GFP fusion protein was 
examined directly from transfected cell culture in 6 
well/plate flask (NUNC) under flurescence microscope 
using a GFP special filter. 
For Western blotting, initially total protein of each 
sample was extracted from PBS resuspended cell pellets 
by dissolving in 50 l SDS reducing buffer (50 mM 
Tris-HCl pH 6.8, 100 mM DTT, 2% SDS, 20% glycerol 
& 0.2 mg/ml bromophenol blue). After heating at 96oC 
for 10 min, the mixture was centrifuged at 14,000 RPM 
in room temperature to separate the protein from the 
cell debris. The proteins were separated on a 10% SDS 
polyacrylamide gel by electrophoresis and transferred 
onto nitrocellulose membranes (Amersham Pharmacia). 
The transferred membrane was immunoblotted with 
primary antibodies (goat anti-GFP, Roche) at 1:10000 
in blocking buffer (PBST-5% skim milk). 
Subsequently, the membrane was incubated with 
secondary antibody (goat anti rabbit IgG) at final 
dilution 1:10000 in blocking buffer. Immunodetection 
was performed by the chemiluminescence method using 
ECL reagents kit (GE Healthcare), and then exposed to 
light sensitive film. 
RESULTS AND DISCUSSION 
Fusion of H5 gene to the C-terminus of GFP 
The H5 gene of the H5N1 isolate was successfully 
inserted into the pEGFP-C1 expression vector. The 
screening test by PCR identified several clones that 
positively contained full-length of H5 gene. These 
positive clones were identified as pEGFP-C1/H5 
(Figure 1A). In addition, digestion with double 
restriction endonucleases (ApaI & XhoI) demonstrated a 
1,707 bp insertion of H5 genes along with the expected 
4.7 kbp of vector fragment (Figure 1C). The sequencing 
of these recombinants recognized several single 
nucleotide polymorphisms (SNP’s) between these 
clones. Therefore, one clone of pEGFP-C1/H5#26.8 
was selected for further gene expression study in cell 
culture since it comprises similar sequence as the 
parental gene. 
In vitro expression level of hemagglutinin gene 
The expression of the H5 gene fused to GFP 
demonstrated low expression in three different cells. 
The native H5 gene in the GFP fusion system was most 
poorly expressed in CEF and RK13. The expression 
level of GFP fusion protein slightly increased in the 
VERO culture. The level of in vitro expression of GFP-
H5 fusion protein in cell cultures is shown in Figure 2B, 
2E and 2H. Although, expression was demonstrated in 
all cultures by fluorescence, Western blotting revealed 
production of GFP-H5 fusion protein only in VERO 
(Figures 3C). 
Fusion of N1 gene to the C-terminus of GFP 
The cloning the N1 gene into plasmid pEGFP-C1 
expression vector was successfully carried out from 
clone pGEM-TE/N1#15. The PCR test was utilised to 
identify clones of pEGFP-C1 expression vector carrying 
N1 full-gene. The positive clones of plasmid pEGFP-C1 
were identified as pEGFP-C1/N1#15 (Figure 1B). The 
restriction pattern of this recombinant clone using ApaI 
& XhoI double digestion demonstrated the insertion of 
1,350 bp of N1 gene into 4.7 kbp of vector fragment 
(Figure 1D). Sequencing of these clones confirmed that 
all clones were consistent to the parental gene. 
In vitro expression level of neuraminidase gene 
The expression of the N1 gene products fused to 
GFP was observed in all transfected cell lines. The 
observation using fluorescence microscopy on GFP 
fusion protein confirmed for maximum expression at 48 
h after transfection. In addition, the expression level of 
GFP fusion protein was higher using the cell line 
(RK13 & VERO) compared the CEF primary cell 
culture (Figures 2C, 2F & 2I). Moreover, the Western 
blotting analysis in this N1 clone was detected GFP-N1 
fusion protein in all three types of cell culture (Figures 
3A-C). 
Comparison of expression level between H5 and N1 
genes 
The experimental results demonstrated clear 
differences of in vitro expression levels of the H5 and 
JITV Vol. 16 No. 3 Th. 2011: 234-241 
 
 238 
N1 genes in CEF, RK13, and VERO cell culture 
systems. It appears that the recombinant proteins were 
better expressed in the VERO mammalian cell, 
suggesting this cell is more suitable for expression of 
foreign gene. Although the H5 and N1 genes were 
originally derived from an avian virus, these genes were 
poorly expressed on primary CEF cell culture. 
Apparently, the primary CEF cells were not suitable for 
gene expression studies, which might be due to low 
transfection efficiency of this cell. As the control GFP 
worked well, the expression of H5 gene was generally 
observed to be low in these cultures with only a small 
quantity of the protein detected by Western blotting 
analysis. In contrast, the N1 gene was expressed at a 
higher level compared to H5. This evidence supports 
the premise that the highly variance of codon usage 
pattern in the H5 gene sequence may negatively affect 
the expression level of the gene. 
It is also suspected that the regulation of H5 gene 
expression in the naive infection involves viral helper 
genes. If the production of H5 protein requires 
processing of some sort by other viral proteins, the 
individual expression of H5 gene will be negatively 
affected by the absence of these proteins. In the studies 
by FODOR et al. (1999) and HOWARD et al. (2007), the 
presence of four additional protein expression plasmids 
containing PB1, PB2, PA, and NP gene increased the 
efficiency of the rescue system of all eight genomic 
segments of influenza virus in the reverse genetics 
studies. However, the significance of these four genes 
still requires clarification for influencing different levels 
of expression the H5 and N1 genes demonstrated in this 
study. These reverse genetics studies are more reflective 
of native virus replication where co-expression of all 
eight genes occurs at the same time rather than 
individual gene expression as conducted in this study. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Construction of expression plasmid pEGFP-C1 carrying full-length of H5 and N1 genes: (A) PCR screening of 26 clones for 
identification H5 full gene of the recombinant pEGFP-C1/H5#26; (B) PCR screening of 26 clones for identification N1 full gene of 
the recombinant pEGFP-C1/N1#15; (C) Double digestion with XhoI & ApaI for the recombinant pEGFP-C1/H5#26 (clone 2, 5, 8, 13, 
17, 20, 22, 24); (D) Double digestion with XhoI & ApaI for the recombinant pEGFP-C1/N1#15 (clone 2, 4, 7, 12, 15, 19, 21, 23) 
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Figure 2. Expression level of the pEGFP-C1 carrying H5 and N1 gene in cell cultures after 48 h incubation: (A) pEGFP-C1 (control) in CEF 
cells; (B) pEGFP-C1/H5 in CEF cells; (C) pEGFP-C1/N1 in CEF cells; (D) pEGFP-C1 (control) in RK13 cells; (E) pEGFP-C1/H5 in 
RK13 cells; (F) pEGFP-C1/N1 in RK13 cells; (G) pEGFP-C1 (control) in VERO cells; (H) pEGFP-C1/H5 in VERO cells; (I) 
pEGFP-C1/N1 in VERO cells 
 
The expression study of native H5 and N1 genes in 
RK13 cell using pCDNA3 by PAVLOVA et al. (2009) 
generated poor expression for both genes. This result 
concurred with the expression of H5 gene of the current 
study but it displayed different outcome for the 
expression of N1 gene. However, these reseachers  were  
 
 
 
 
 
 
able to enhance the individual expression of H5 and  N1  
genes in RK13 cell by inserting a synthetic intron 
sequence in the upstream region. Therefore, this 
outcome sugest that testing wider range of expression 
vector genetic elements may improve the expression 
level of HA and NA genes. 
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Figure 3. Western blotting analysis of GFP-H5/N1 fusion protein in cell culture after 48 h incubation: (A) gene expression in CEF culture; (B) 
gene expression in RK13 culture; (C) gene expression in VERO culture. Green arrow indicates presence of GFP protein; red arrow 
indicates GFP-H5 fusion protein, whilst blue arrow indicates GFP-N1 fusion protein 
 
CONCLUSIONS 
 
The native N1 gene was expressed higher by 
comparison with the native H5 gene in GFP 
recombinant system. In point of fact, the level 
expression of H5 gene as GFP fused protein was very 
low. These findings have implications for the utilisation 
of native H5 and N1 genes in recombinant systems, 
whereas the native N1 gene could be utilised in 
recombinant system, the native H5 gene would need to 
be optimised before it could be used for recombinant 
purposes. 
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